MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG

The present application describes RGM A binding proteins, particularly monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, which have the ability to bind to RGM A and prevent binding of RGM proteins to RGM A receptor and other RGM A binding proteins, and therefore neutr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: MÜLLER, BERNHARD, K
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MÜLLER, BERNHARD, K
description The present application describes RGM A binding proteins, particularly monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, which have the ability to bind to RGM A and prevent binding of RGM proteins to RGM A receptor and other RGM A binding proteins, and therefore neutralize the function of RGM A, for use in the treatment of retinal nerve fiber layer (RNFL) degeneration as well as methods of therapeutically or prophylactically treating a mammal against RNFL degeneration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK2510001TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK2510001TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK2510001TT33</originalsourceid><addsrcrecordid>eNqNjMEKgkAURd20iOofXh8gaNIHjM0dHRzfxPRwKxLTKkow6PcT6wNaXQ73cNbJu_XsG-dZOZBisRfxxiBQ6zWFqiWVnoMXWIaQWDc7HVjDXbBgiVqxdpYrUoY0KjCCEuv5y0IBYpf6fHQwtkRwqtomq9twn-Lut5tkbyCnOo3js4_TOFzjI7563RyOeZZluUhR_ON8AFVIOcU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG</title><source>esp@cenet</source><creator>MÜLLER, BERNHARD, K</creator><creatorcontrib>MÜLLER, BERNHARD, K</creatorcontrib><description>The present application describes RGM A binding proteins, particularly monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, which have the ability to bind to RGM A and prevent binding of RGM proteins to RGM A receptor and other RGM A binding proteins, and therefore neutralize the function of RGM A, for use in the treatment of retinal nerve fiber layer (RNFL) degeneration as well as methods of therapeutically or prophylactically treating a mammal against RNFL degeneration.</description><language>dan</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160229&amp;DB=EPODOC&amp;CC=DK&amp;NR=2510001T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160229&amp;DB=EPODOC&amp;CC=DK&amp;NR=2510001T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MÜLLER, BERNHARD, K</creatorcontrib><title>MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG</title><description>The present application describes RGM A binding proteins, particularly monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, which have the ability to bind to RGM A and prevent binding of RGM proteins to RGM A receptor and other RGM A binding proteins, and therefore neutralize the function of RGM A, for use in the treatment of retinal nerve fiber layer (RNFL) degeneration as well as methods of therapeutically or prophylactically treating a mammal against RNFL degeneration.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKgkAURd20iOofXh8gaNIHjM0dHRzfxPRwKxLTKkow6PcT6wNaXQ73cNbJu_XsG-dZOZBisRfxxiBQ6zWFqiWVnoMXWIaQWDc7HVjDXbBgiVqxdpYrUoY0KjCCEuv5y0IBYpf6fHQwtkRwqtomq9twn-Lut5tkbyCnOo3js4_TOFzjI7563RyOeZZluUhR_ON8AFVIOcU</recordid><startdate>20160229</startdate><enddate>20160229</enddate><creator>MÜLLER, BERNHARD, K</creator><scope>EVB</scope></search><sort><creationdate>20160229</creationdate><title>MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG</title><author>MÜLLER, BERNHARD, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK2510001TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MÜLLER, BERNHARD, K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MÜLLER, BERNHARD, K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG</title><date>2016-02-29</date><risdate>2016</risdate><abstract>The present application describes RGM A binding proteins, particularly monoclonal antibodies, and in particular CDR grafted, humanized versions thereof, which have the ability to bind to RGM A and prevent binding of RGM proteins to RGM A receptor and other RGM A binding proteins, and therefore neutralize the function of RGM A, for use in the treatment of retinal nerve fiber layer (RNFL) degeneration as well as methods of therapeutically or prophylactically treating a mammal against RNFL degeneration.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK2510001TT3
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title MONOKLONALE ANTISTOFFER MOD RGM A-PROTEINET TIL ANVENDELSE TIL BEHANDLING AF DEGENERATION AF DET RETINALE NERVEFIBERLAG
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T01%3A48%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=M%C3%9CLLER,%20BERNHARD,%20K&rft.date=2016-02-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK2510001TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true